Every life sciences company, whether biotech, diagnostics, or medtech, hits key inflection points where hiring needs evolve faster than internal capacity. Early-stage firms may rely on founders and scientific leaders to make critical hires. But as funding milestones are reached and pipelines mature, the question emerges: Do we continue managing recruitment in-house, or is it time to bring in external expertise?

Recognizing these turning points is crucial for maintaining momentum without overextending internal resources or missing out on top talent.

The Early Build Phase: Hands-On, Founder-Led Hiring

In the earliest stages, resources are tight, culture is still forming, and leaders are deeply involved in every hire. Internal recruitment often looks like spreadsheets, networks, and referral-driven searches. At this phase, external partners can still add value, especially for specialized roles (CMC, regulatory affairs, or clinical development) where time-to-fill and expertise matter more than volume.

The inflection point arrives when ad-hoc hiring starts to slow progress or distract core leadership from mission-critical work.

The Growth Phase: Structure Meets Scale

Once a company secures Series B or C funding, hiring often accelerates when new departments form, headcount projections double, and compliance demands increase. This is when an internal talent acquisition team begins to make sense. Dedicated recruiters can embed within departments, represent the employer brand, and ensure consistency in candidate experience.

But even a well-staffed team can hit limits. High-volume hiring sprints, confidential executive searches, or new market expansions often stretch internal capacity or ability. Here, an external search partner acts as an extension of your team, providing surge capacity, specialized networks, and targeted outreach where needed most.

The Maturity Phase: Complexity and Specialization

As organizations mature, hiring complexity rises. You may be entering new therapeutic areas, global markets, or integrating after an acquisition. Internal recruiters know the business well, but they can’t always reach passive senior talent or build pipelines in unfamiliar domains.

External partners can complement this by focusing on high-impact leadership and niche technical roles, positions where confidentiality, precision, and industry insight are essential. Collaboration between internal and external teams creates a hybrid model that offers both speed and strategic depth.

How to Decide

When evaluating whether to build or partner, consider:

• Hiring velocity: Are internal resources keeping pace with demand?
• Role complexity: Do roles require specialized industry knowledge or confidential outreach?
• Strategic focus: Are leaders spending too much time recruiting instead of executing growth initiatives?
• Cost efficiency: Would external partnership reduce time-to-fill or mitigate the risk of a mis-hire?

Building the Right Model for Your Stage

There’s no one-size-fits-all approach to talent acquisition. What matters most is timing, knowing when your organization has reached an inflection point that demands a shift in approach. Life sciences success depends not just on innovation, but on assembling the right people at the right moments of growth.

If your company is approaching one of those turning points, GeneCoda® can help you assess your current strategy and design a balanced model that aligns with your goals. Contact us to discuss how an adaptive hiring approach can power your next phase of growth.

If you’ve spent time in today’s life sciences job market, whether as a hiring leader or a candidate, you’ve likely encountered something unsettling: ghost job posts. These are job ads that appear active but are not truly open, funded, or intended to be filled anytime soon.

On the surface, they may seem harmless. After all, companies sometimes post roles to build pipelines or gauge talent availability. But in practice, ghost postings create real and measurable damage, to employer brands, recruiting efficiency, and overall market trust. Continue reading “Ghost Jobs Are Spooking Your Talent Pipeline? Here’s Why It Matters”

What You Lose When a Star Leaves

Losing a top performer isn’t just a headline metric, it’s a disruption. Whether it’s a seasoned regulatory affairs leader, a clinical operations head, or a VP of R&D, when someone highly capable departs, you lose institutional knowledge, momentum, and the relationships that often drive successful programs forward. Research consistently points to familiar reasons: lack of growth, stifling bureaucracy, misaligned leadership, or a vision that doesn’t resonate.

In our industry, where science, regulation, commercialization, and team dynamics intersect, the cost of mis-retaining a key leader can show up as delayed launches, regulatory missteps, or a competitor snapping up that person’s next move. Continue reading “Why You Can’t Afford to Let Your Leaders Go”

Beyond “Build a Course”

In fast-moving biotech and pharma organizations, when a manager or hire asks for training, the instinct is often to say “Yes, let’s build this program” or “No, that’s not our priority.” But this binary response can lock your team into a reactive mode, rather than a strategic one. Instead of jumping straight to a solution, what if you treated every request as a doorway into deeper insight about what your people truly need?

Continue reading “When Training Isn’t the Answer”

Redefining What “Ready” Really Means

In the life sciences world, leadership roles often carry a long list of credentials: advanced degrees, long tenures at big pharma, specific titles, and affiliations. But what if we shifted our focus from credentials to capabilities? The skills-first hiring movement invites us to ask: What can this person do, and how will they grow in our environment? Continue reading “Focusing on Skills, Not Status”

Roles in biochemistry, regulatory affairs, clinical operations, and translational research demand deep subject-matter rigor, niche experience, and high alignment to mission. Because of that, your Talent Acquisition (TA) team needs structure that supports precision, speed, and credibility, not just volume.

Here’s a guide for designing a TA function that works effectively for life sciences. Continue reading “Designing a Talent Acquisition Team That Powers Growth”

When you apply for an executive role in life sciences, whether in biotech, pharmaceutical R&D, medical devices, or regulatory affairs, everything counts: your resume, your reputation, and yes, your cover letter. But too often, cover letters are either generic templates or polished fluff. They don’t reflect you. 

In 2025, with so many senior leadership positions vying for authenticity and impact, the cover letters that get noticed are the ones that weave personal voice, relevant scientific leadership, and mission-driven storytelling. Here’s how to write one that stands out and aligns with what life sciences hiring decision-makers really want.  Continue reading “Crafting Executive Cover Letters That Make Life Sciences Leaders Stand Out”

The COVID-19 pandemic accelerated a shift toward remote and hybrid work environments, fundamentally altering how organizations approach hiring. In the life sciences sector, where precision, collaboration, and innovation are paramount, the question arises: Should we return to in-person interviews for executive roles?  Continue reading “Reevaluating In-Person Interviews in Life Sciences. A Strategic Perspective”

Trust, long-term collaboration, and reputation often matter more than anything else, the relationships you’ve built, even years ago, can be powerful. Yet many executives overlook former colleagues, professors, or peers because they think it’s awkward, or believe “too much time” has passed. That’s a missed opportunity. 

Reaching out to former connections, people you haven’t talked with in years, can pay off. Especially when you approach with authenticity. In our world of biotech, pharma, clinical research, and medtech, those reconnections can translate into advisory roles, referrals, or even leadership opportunities.  Continue reading “Rekindling Old Connections. How Executives Can Leverage LinkedIn to Re-Open Doors”